US Schizophrenia Drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The US schizophrenia drugs market is projected to grow at a significant CAGR of 2.7% during the forecast period (2020-2026). The rising awareness programs for mental health is acting as one prominent factor in the market growth in the US. The first Wednesday in November each year is celebrated as National Stress Awareness Day in the US. Various programs are conducted on this day to create awareness related to the treatment available for the management of schizophrenia. The increasing awareness in the country related to the treatment of schizophrenia is further supporting the growth of the market for schizophrenia drugs. Even though the anxiety disorder is highly treatable, only around one-third of people that suffer from this disorder receive treatment. Moreover, as per the report of the WHO, anxiety disorder is the most prevalent mental disorder in the country with social phobia and specific phobia as its most common form.
To Request a Sample of our Report on US Schizophrenia Drugs Market: https://www.omrglobal.com/request-sample/us-schizophrenia-drugs-market
Further, Stanford University
launched an initiative in 2018. The initiative's goal is to establish and
maintain a forum to tackle global mental health as a priority. This program
would combine activities focused on global mental health in healthcare,
science, sports, and education which is expected to immensely assist the growth
of schizophrenia drugs market. In addition, the new program would draw together
the current activities of the faculty and provide opportunities for new
collaborations and initiatives. A core component of the project is the use of
IT resources to extend mental health programs across the globe, taking
advantage of Silicon Valley's expertise.
A full
Report of US Schizophrenia Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-schizophrenia-drugs-market
·
Second
Generation Antipsychotics
·
Third
Generation Antipsychotics
·
Others
(First Generation Antipsychotics)
By Treatment
·
Oral
·
Injectables
Company Profiles
·
Alkermes
PLC
·
Allergan
PLC
·
AstraZeneca
PLC
·
Biogen
Inc.
·
Catalent,
Inc.
·
Eli
Lilly and Co.
·
H.
Lundbeck A/S
·
Indivior
PLC
·
Johnson
& Johnson Services, Inc.
·
Lupin
Ltd.
·
Merck
& Co., Inc.
·
Minerva
Neurosciences, Inc.
·
Otsuka
Pharmaceutical Co., Ltd.
·
Pfizer
Inc.
·
Sunovion
Pharmaceuticals Inc.
·
Teva
Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-schizophrenia-drugs-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment